TP53 and hepatocellular carcinoma: In a mouse model of hepatocellular carcinoma, activated p53 was found to increase NK cell recognition and infiltration through a decay-inducing program, which was not dependent on NKG2D but rather correlated with cytokines (IL-12, IL-15, IL-18, CCL2, and CCL3) produced by activated p53.